Financing channel feed – Endpoints News

Financing channel feed

Ascletis reaps record $400M from Hong Kong investors in the exchange's first-ever pre-revenue biotech listing

7 years ago

With a new HQ under construction and AbbVie as a partner, Alector grabs $133M round to fund a move into the clinic

7 years ago

Faheem Hasnain ups cash haul to $330M for a fledgling biotech that is moving ‘at light speed’

7 years ago

This week’s Nasdaq casino winnings: About $700M for 6 biotech IPOs as shares start moving north

7 years ago

Post-Bristol/Myers buyout, the IFM team lines up $31M to tackle a troika of NLRP3 targets

7 years ago

Aridis Pharma seeks $35M to fight infections with immunotherapies — latest in an IPO streak

7 years ago

Armed with $36M A round, Johns Hopkins spinout Neuraly heads to PhI Parkinson's trial

7 years ago

By the numbers: Series A rounds are busting out, platforms are in, M&A is down, valuations surge and 2018 looks wicked big

7 years ago

Boom time: Rubius, Crinetics find big support in upsized IPOs totaling $343M raise

7 years ago

Pre-revenue vaccine developer CanSino lines up at a buzzing HKEX

7 years ago

On its way to making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO

7 years ago

The next Nimbus? Head of billion-dollar drug program launches HotSpot with $45M A round

7 years ago

Fast-growing Ascentage has big plans for its latest $150M raise -- but what about the IPO?

7 years ago

Chasing Biogen, the Pliant crew banks a $62M round to fuel their shot at fibrosis targets

7 years ago

Backers of Tesla and SpaceX fund 29-year-old Alice Zhang's AI-powered neuroscience startup

7 years ago

A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino

7 years ago

Vant commander Ramaswamy heads back to Nasdaq with a $150M pitch — are investors ready to forgive Axovant?

7 years ago

Biogen vet George Scangos jumps on the board at upstart MS case manager Octave, backed by Section 32

7 years ago

Thiel-backed Compass adds $49M to A round, bringing total to $132M

7 years ago

12 top China VCs you need to know who are making a transpacific splash (Part 2)

7 years ago

Forbion raises $316M to tap the potential of European biotech plays

7 years ago

As biotech funds sprout around the globe, Sanofi and government bank are setting up a $292M operation in France

7 years ago

7 things you need to know now about raising biotech cash in China (Part 1)

7 years ago

A roaring Rubius sets out to snag $1.8B market cap in $200M IPO

7 years ago

First page Previous page 124 125 126127128 129 130 Next page Last page